Objectives: To determine the differences in costs and complications in patients with bicondylar tibial plateau (BTP) fractures treated with 1-stage definitive fixation compared with 2-stage fixation after initial spanning external fixation.
INTRODUCTION
Bicondylar tibial plateau (BTP) fractures typically result from high-energy injuries associated with significant soft tissue insult. The timing of definitive surgical fixation is dictated by the surgeon's subjective assessment of the soft tissues in the zone of injury. Immediate definitive fixation through compromised soft tissue historically led to high rates of wound complications and deep infection. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Therefore, 2-stage treatment allowing for resolution of acute soft tissue injury is a common strategy to reduce complication risk. This involves initial application of an external fixator, followed by delayed definitive fixation within 1 to 3 weeks. [13] [14] [15] [16] Alternative strategies to avoid early open surgery include percutaneous fixation and definitive external fixation. 15, [17] [18] [19] [20] [21] [22] [23] The benefits of 2-stage treatment come with higher monetary costs related to multiple procedures, additional implants, and prolonged or repeat hospitalizations. In addition, delayed definitive treatment may increase the difficulty of fracture reduction. These drawbacks of staged treatment make early definitive fixation preferable in appropriately selected patients at low risk of soft tissue complications.
Recent reports have suggested that early definitive fixation is safe for lower extremity fractures when careful patient selection and sound surgical techniques are used. 24, 25 The purpose of this study is to compare the outcomes and costs between BTP fractures treated in 1 versus 2 stages. We hypothesized that (1) outcomes of surgically treated BTP fractures would be equivalent for 1-versus 2-stage treatment with appropriate patient selection for each pathway and (2) 1-stage treatment would have significantly lower costs.
PATIENTS AND METHODS
We performed a retrospective review of all complete articular BTP fractures (OTA/AO 41-C and Schatzker 6) treated at our Level 1 trauma center by 1 of 6 fellowshiptrained orthopaedic traumatologists from 2013-2015. Inclusion criteria were age $17 years and follow-up to 1 of 2 end points: healed fracture (minimum 6 months) or diagnosis of nonunion. Patients were identified by searching current procedural terminology billing codes submitted by the treating surgeon for open treatment of BTP fractures (27536). Patients with partial articular fractures (OTA/AO 41-B), compartment syndrome, Gustilo type 3 open fractures, and those not definitively treated with open reduction and internal fixation (ORIF) were excluded. In addition, patients hospitalized with prolonged delay (more than 3 days) to surgery for reasons unrelated to their knee injury were excluded because the resultant "artificial" increase in the cost of care would confound study results.
In this series of patients, time to fixation was based on surgeon assessment of the soft tissue envelope. Although there is no universally accepted objective criteria to define acceptable soft tissues, fracture blisters were considered a contraindication, but absence of skin tension and "wrinkle test" was not used because of subjectivity. In general, the decision for 1-stage versus 2-stage treatment was based on the status of the soft tissues at the time of the index surgery. The possibility of postoperative deterioration of the soft tissue envelope was typically not a consideration when choosing the treatment pathway. Surgeons became more comfortable with this approach later in the study, but as a result, there is a bias toward a more conservative approach earlier in the study. In addition, between the 6 surgeons, there was varying "risk tolerance," particularly early in the study period, which contributes to the selection bias in this study.
Patients were divided into 2 groups. One-stage treatment was defined as ORIF at the index procedure with no immediate plans for additional surgical treatment to revise fracture reduction or fixation. Two-stage treatment was defined as placement of a temporizing knee-spanning external fixator, followed by definitive ORIF at a separate operative session. These definitions allowed for grouping of all patients in our cohort without exception.
For each patient, direct implant-related costs and hospital charges were obtained via in-house customized surgical inventory software and hospital charge data. All cost data are reported in US dollars. Implant charges are reported as list price, and hospital charges are undiscounted. Hospital charges were chosen as a surrogate for hospitalization-related costs because actual cost data are often inaccurate and proprietary. Charges were reported in mean values for normally distributed charges (implant costs) and as medians for nonnormally distributed charges (hospital charges). Total implant costs and hospital charges were compared between groups. A separate subgroup analysis was performed for 2-stage patients treated in a single hospital admission versus those treated over 2 separate hospitalizations. Because of the concern that some patients' hospital charges would be increased as a result of multiple injuries unrelated to the BTP fracture (ie, a potential confounder to cost), an additional analysis was performed including only patients with an isolated BTP fracture (ie, no injuries of any type other than the BTP fracture).
Demographic data, injury characteristics, clinical outcomes, OTA/AO fracture classification, incidence of nonunion, fixation strategies, and fracture alignment after ORIF were compared between groups. Functional outcomes were assessed through the Physical Function (PF) and Pain Interference (PI) domains of the Patient-Reported Outcomes Measurement Information System (PROMIS) score. Fracture union was assessed by radiograph review and medical record documentation.
Student t test, Mann-Whitney U test, and Fisher exact test were used for statistical analyses. A P value of ,0.05 was considered statistically significant.
RESULTS
Applying the inclusion criteria to our current procedural terminology code search yielded 105 patients over a three-year period, of whom 53 were excluded: 24 patients had less than 6 months of follow-up; 14 patients had compartment syndrome; 6 patients were treated with intramedullary nails; 4 patients were treated with ring fixators; 2 patients had ipsilateral transtibial amputations for mangled extremities; and 3 patients had prolonged delay to surgery because of medical issues unrelated to trauma. This resulted in 28 patients in the 1-stage group and 24 patients in the 2-stage group.
Demographics, comorbidities, and fracture characteristics were similar between groups (Table 1) . Mean followup was 21.8 months (range 6-41 months), and 87% of patients had at least 12 months of follow-up. The mean number of days to definitive fixation in the 1-stage group was 1.2 (range 0-3) and was 7.8 (range 3-15) in the 2-stage group. A nonsignificant trend toward an increased reoperation rate was observed in the 2-stage group compared with the 1-stage group (29% vs. 7%, P = 0.06) ( Table 2 ). There were no differences between groups with respect to incidence of deep infection, superficial infection, nonunion, or change in alignment. Functional outcomes at the final follow-up via PROMIS PF and PI were also similar between groups (Table 2) .
One-stage procedures were performed on 50% of the cases in the early study period (2013) and increased to 75% of the cases at the end of the study period (2015). Mean implant Fig. 2 ). Hospital charges for 2-stage cases performed in the same admission were $175,457 compared with cases discharged and readmitted when soft tissues had recovered, for which the median charges were $148,274. This is likely due to a higher percentage of concomitant injuries in the patients who had both stages of their fixation in one admission (9/13 vs. 2/11).
DISCUSSION
Historically, early definitive ORIF for lower extremity periarticular fractures was met with a significant incidence of wound related complications. 1, 5, 12, 15, [26] [27] [28] [29] This led to technique modifications and alternative strategies for soft tissue management. 15, 18, 21, 22, 30, 31 After good initial results were reported with a 2-stage approach in tibial pilon fractures, 32 this technique was adopted in the treatment of tibial plateau fractures. 13, 14 Initial placement of a spanning external fixator was found to restore gross fracture alignment, maintain length, accelerate resolution of soft tissue swelling, and facilitate delayed fixation.
Barei et al 1 reported on the complications of ORIF via dual incisions in 83 high-energy tibial plateau fractures (OTA/ AO 41-C3). Open fractures were present in 13% of the patients, and 50% were treated initially with a spanning external fixator. They stated that the use of a temporizing spanning fixator increased during the study period. Time to definitive surgery averaged 9.2 days (range 0-40), with a 19% major complication rate, including an 8% deep infection rate. These outcomes are similar to our findings, but interestingly, they had an increasing rate of staged procedures during their study period, and we had a decreasing rate during ours. Our decreasing use of staged treatment without an increase in complications may Staged treatment, although usually considered a more conservative and safer strategy, has many potential disadvantages. First, external fixators applied during the first stage are very costly implants. In addition, the prolonged initial admission or readmission for definitive fixation adds significant costs to the treatment of these injuries. Finally, fracture fragment mobility is often diminished when these fractures are fixed 10-14 days after injury, making anatomic reduction more difficult. Prolonged surgery and potential surgical site contamination from the external fixator and pin tracts increase the risks of postoperative infection.
The cost differences between 1-and 2-stage fixation in our cohort result from differences in both implant costs, as well as hospital charges related to additional operations and length of stay. The vast majority of the implant costs differences are attributable to the cost of external fixation. External fixators are among the most expensive implants used in orthopaedics, with complete constructs costing more than most total joint implants. This is due to the multiple components (clamps, bars, etc.) each of which can cost $500 to $1000. These components accounted for 73% of the implant costs in the 2-stage group. Although implant costs and hospital charges were generated differently, implant charges did account for 15% of the difference in charges between the 1-stage and 2-stage patients. The additional costs related to 2-stage treatment are due to the difference in charges for 2-stage versus 1-stage operation and the additional hospital days related to 2-stage treatment. Even excluding implant-related charges, 2 operative sessions (vs. 1) will have increased facility-related operating room charges that add to overall costs. In addition, the higher time to definitive surgery in the 2-stage group, more than half of which were performed during the index admission, added hospital days, and the resultant charges to the 2-stage group. Although multiple injuries can account for some of these increased costs, these differences were still seen in isolated tibial plateau injuries, with the 2-stage hospital costs being nearly double even in the isolated plateau injuries.
In our practice, we noticed an evolution away from the belief that nearly all "high energy" tibial plateau fractures must be treated with a 2-stage approach. Before treatment of this cohort, even when the soft tissues looked amenable to immediate surgery, patients were often treated with a 2-stage approach because of concerns that swelling would progress during and after ORIF, making wound closure difficult and risking wound complications. We began a more aggressive approach using single-stage treatment in appropriately selected patients in 2013. We determined the safety of definitive fixation at the time of the initial surgical encounter using recognized albeit subjective criteria to evaluate the soft tissues. If a fracture was associated with blisters or taut skin, we treated it in a staged fashion using a spanning external fixator. If the skin was felt to be amenable, we proceeded with definitive ORIF regardless of concern for progressive postoperative swelling. We used modern surgical technique including separate medial and lateral incisions rather than midline incisions (when open access was needed both medially and laterally), careful soft tissue handling, and minimal periosteal stripping. Although there was not a statistically significant difference in complication rates between the 2 groups in this study, there was a trend toward fewer complications in the early fixation group (7% vs. 29% unplanned reoperation and 7% vs. 17% deep infection). The potential selection bias in our study does not allow definitive explanation of this trend, but possible explanations include higher severity of injury or the difficulty of fixation in the staged group lead to a higher complication rate.
Recent studies have reported acceptable results in both tibial pilon and plateau fractures in appropriately selected patients using contemporary surgical techniques. 24, 25 Unno et al 24 recently reported on a cohort of 102 nonconsecutive OTA/AO 41C fractures, most treated in 1 stage less than 72 hours from injury. They treated 91% with 1 operation, and 82% of these were treated with ORIF mostly (71%) through a single lateral approach. They had an aggressive interpretation of soft tissue readiness, using only 2-stage treatment in the face of circumferential blisters, necrosis, and medical issues preventing early surgery. They did not feel that a "wrinkle sign" was an important factor in determining soft tissue readiness. Reoperation within 12 months occurred in 16% of patients. They had adequate reductions in 95% of cases, and patient-reported outcomes were similar to previous reports of BTP fractures. A major difference in our cohort may arise from the criteria used to assign patients to 1 versus 2-stage treatment. Although we were fairly aggressive in proceeding with early definitive ORIF (54%), the criteria we used to determine 1-stage treatment were much more conservative than those used by Unno et al (91% treated in 1 stage) .
This investigation has a number of limitations. The number of patients in each group is somewhat low because of focus on a very specific fracture pattern (Schatzker 6, OTA/AO 41-C). This limits the power of our study to draw conclusions regarding the lack of statistically significant differences in clinical and radiographic outcomes, but our conclusions regarding the cost implications of 1-versus 2-stage treatment remain valid. In addition, a minimum of 6 months of follow-up was set for inclusion in an attempt to truly understand all the ramifications of 1-versus 2-stage surgery on BTP fractures. We chose 6 months as our minimum follow-up because we believed that that was sufficient follow-up to identify the complications mostly associated with the decision for 1-versus 2-stage treatment, namely, wound healing complications.
However, this follow-up could be too short to identify radiographic or functional outcome differences between the 2 treatment methods in this cohort.
Another limitation of this study is the subjective nature of soft tissue assessment when determining whether 1-or 2-stage treatment should be undertaken. There is no validated, objective, reproducible soft tissue scoring system that can quantify the extent of soft tissue injury. Therefore, extrapolation of our results to other centers may be difficult.
Selection bias is a limitation of most retrospective studies, and it is here as well. However, 96% of the fractures in the study were OTA/AO 41-C3 fractures. Therefore, using the best fracture classification scheme available, there were no significant differences in fracture severity between the groups. We acknowledge, however, that there can be different severity of injury within the C3 group. In addition, if one assumed that more severe injuries were more likely to be treated conservatively with a 2-stage approach, one could expect the wound complication rate for the 2-stage group to be lower, which was not.
Using hospital charges as a surrogate for the cost of hospitalization is another limitation. True hospital costs, which would be the ideal metric, are nearly impossible to obtain, are not uniformly reported, and are somewhat proprietary. Hospital collections would be subject to differences in payor mix and contractual adjustments. Although hospital charges can certainly vary widely, they are accurate, independent of payor, and readily available.
We used PROMIS Physical Function and Pain Interference as our patient-reported outcomes because we record these prospectively for all patients at regular office follow-up. Although increasingly common, these validated PROMIS scores have not been widely used in other orthopaedic studies, making result comparison between studies difficult. Because of the retrospective nature of our study, we did not collect WOMAC or Olerud outcomes, which have commonly been reported in other tibial plateau fracture studies.
CONCLUSIONS
This study demonstrated that single-stage definitive treatment of BTP fractures without staged external fixation dramatically decreases costs without an increase in complications in appropriately selected patients. The retrospective nature of this investigation lends itself to selection bias with respect to the level of injury severity in each group. Future prospective studies may better define appropriate selection criteria for early definitive fixation of BTP fractures.
